European Archives - Page 683 of 899 - European Medical Journal

Continue
2 Mins
3rd August 2017

Leukotriene Receptor Antagonists in Managing Severe Uncontrolled Asthma

Leukotriene receptor antagonist in treatment is important for monitoring disease evolution and success of therapy in patients with asthma.
1 Mins
3rd August 2017

Thunderstorm-Related Respiratory Allergy

There are descriptions of asthma outbreaks associated with thunderstorms in several Australian cities, especially during the pollen seasons.
3 Mins
2nd August 2017

Breastfeeding: A No-Cost Investment for Life-long Health

How many of us know we observe World Breastfeeding Week (WBW) from 1st–7th August, every year? World Breastfeeding Week is co-ordinated by the World…
2 Mins
1st August 2017

Introducing EMJ Rheumatology 4.1

United Kingdom, August 01, 2017: A warm welcome to EMJ Rheumatology 4.1, a journal that aims to bring healthcare professionals up to date on the latest…
August 2017

EMJ Rheumatology 4.1 2017

A warm welcome to EMJ Rheumatology 4.1, a journal that aims to bring healthcare professionals up to date on the latest advances in this fast-paced field.
13 Mins
1st August 2017

Review of the 18th European League Against Rheumatology Congress 2017

The 2017 event marked the 70th anniversary of the EULAR society, and the organising committee ensured that the celebrations did not go unnoticed!
2 Mins
1st August 2017

Prevalence and Significance of Anti-Saccharomyces Cerevisiae Antibodies in Primary Sjögren’s Syndrome

Saccharomyces cerevisiae is a common yeast used in the food industry.
2 Mins
1st August 2017

Development of a 37-Channel Mass Cytometry (CyTOF) Panel to Predict Treatment Response in Rheumatoid Arthritis

Treating the inflammation of rheumatoid arthritis early leads to less disability and improved patient outcomes.
11 Mins
1st August 2017

Biosimilars and Switching: What is your Perspective?

The licensing of biosimilars heralds the start of a new era for physicians treating immune and inflammatory diseases.
9 Mins
1st August 2017

Switching Patients from Originator to Biosimilar Medications in Rheumatoid Arthritis: Limiting The ‘Nocebo’ Effect

Biosimilars have been available in Europe since 2006, and biosimilars of monoclonal antibodies since 2013, and are now a widespread clinical reality.